Ana Africa Martin
Overview
Explore the profile of Ana Africa Martin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
62
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mora E, Montoro J, Balaguer A, Rovira M, Cabrero M, Heras I, et al.
Bone Marrow Transplant
. 2024 May;
59(8):1137-1145.
PMID: 38755458
Total body irradiation (TBI)-based conditioning regimens are generally recommended for allogeneic HSCT (allo-HSCT) in patients with acute lymphoblastic leukemia (ALL). Recent evidence suggests that modern chemotherapy-based regimens may be as...
2.
Navarro-Bailon A, Lopez-Parra M, Veiga-Vaz A, Villaron E, Diez-Campelo M, Martin A, et al.
Cytotherapy
. 2024 May;
26(8):806-812.
PMID: 38727653
Background Aims: Cytopenias after allogeneic stem cell transplantation (allo-SCT) are a common complication, the underlying pathogenic mechanisms of which remain incompletely understood. Multipotent mesenchymal stromal/stem cell (MSC) therapy has been...
3.
Rejeski K, Blumenberg V, Iacoboni G, Lopez-Corral L, Kharboutli S, Hernani R, et al.
Hemasphere
. 2023 Apr;
7(4):e858.
PMID: 37038465
Early fever after chimeric antigen receptor T-cell (CAR-T) therapy can reflect both an infection or cytokine release syndrome (CRS). Identifying early infections in the setting of CRS and neutropenia represents...
4.
Hernandez Sanchez J, Lumbreras E, Diez-Campelo M, Gonzalez T, Lopez D, Abaigar M, et al.
Pharmacogenomics J
. 2020 Feb;
20(5):664-671.
PMID: 32015457
The iron chelator deferasirox is widely used in patients with iron overload. Patients with low-grade myelodysplastic syndromes (MDS) get transfusion dependency and need to be treated with deferasirox to avoid...
5.
Hernandez-Sanchez M, Kotaskova J, Rodriguez A, Radova L, Tamborero D, Abaigar M, et al.
Leukemia
. 2018 Sep;
33(2):518-558.
PMID: 30209402
No abstract available.
6.
Bastida J, Cano-Mozo M, Lopez-Cadenas F, Vallejo V, Merchan S, Santos-Monton C, et al.
Medicine (Baltimore)
. 2018 Feb;
96(47):e8669.
PMID: 29381944
Background: Acquired hemophilia A (AHA) is a rare bleeding disease caused by autoantibodies against factor VIII. Spontaneous bleeding symptoms usually affect the skin and muscle, while pericardial effusion is an...
7.
Gonzalez-Gascon Y Marin I, Martin A, Hernandez-Sanchez M, Robledo C, Hermosin M, de Las Heras N, et al.
Eur J Haematol
. 2016 Oct;
98(2):142-148.
PMID: 27717146
Objective: The objective of this study was to analyse by FISH the frequency and prognostic impact of hyperdiploidy in CLL. Method: A review of 1359 consecutive cases diagnosed with CLL...
8.
Forero-Castro M, Robledo C, Benito R, Abaigar M, Martin A, Arefi M, et al.
PLoS One
. 2016 Feb;
11(2):e0148972.
PMID: 26872047
Unlabelled: Identifying additional genetic alterations associated with poor prognosis in acute lymphoblastic leukemia (ALL) is still a challenge. Aims: To characterize the presence of additional DNA copy number alterations (CNAs)...
9.
Hernandez J, Hernandez-Sanchez M, Rodriguez-Vicente A, Grossmann V, Collado R, Heras C, et al.
PLoS One
. 2015 Dec;
10(11):e0143073.
PMID: 26630574
To analyze the impact of the 11q deleted (11q-) cells in CLL patients on the time to first therapy (TFT) and overall survival (OS), 2,493 patients with CLL were studied....